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Intraplaque Hemorrhage: Most Dangerous Is the
Wound That Bleedeth Inwardly. . .*
Aloke V. Finn, MD,† Jagat Narula, MD, PHD‡ata linking intraplaque hemorrhage with
atherosclerosis lesion progression have
mainly been derived from pathological
studies (1). In the individuals who had
died of sudden cardiac death, the frequency of
previous intraplaque hemorrhage (IPH) in the
culprit coronary atherosclerotic lesions or the le-
sions prone to rupture, was greater than that seen
in early lesion morphologies or in stable plaques.
The extent of IPH corresponded positively to the
size of the necrotic core suggesting a relation be-
tween hemorrhage, core expansion, and plaque pro-
gression. These changes were paralleled by an in-
crease in macrophage density, indicating that
hemorrhage also served as an inflammatory stimulus.
Prospective imaging studies in living patients
linking hemorrhage to plaque progression and in-
stability have only recently begun to emerge.
There are no known imaging modalities to iden-
tify hemorrhage in human coronary arteries in
vivo, and this paradigm has predominantly been
investigated in carotid arteries. In serial magnetic
resonance imaging studies, IPH has been ob-
served to be associated with an increase in ne-
crotic core size and plaque burden over an 18-
month follow up period (2). In this issue of
iJACC, Sun et al. (3) have extended these previ-
ous observations by conducting 3 serial magnetic
resonance imaging studies conducted every 18
months in subjects with evidence of IPH in ca-
rotid artery lesions (3). The rates of plaque pro-
gression after the occurrence of IPH were higher
when compared to the period prior to IPH. Con-
sistent with other studies, these data suggest that
*Modified from an Arabic proverb. From †Emory University Hospital,
Atlanta, Georgia; and the ‡Zena and Michael A. Wiener Cardiovascular
Institute, Mount Sinai School of Medicine, New York, New York.IPH has long-standing deleterious effects on
plaque growth. Moreover, the fact that IPH re-
mained detectable out to 3 years suggests either
that IPH may stimulate recurrent hemorrhage or
that it does not resolve quickly.
How does IPH stimulate plaque progression? Increas-
ing necrotic core size is a critical morphological
feature that distinguishes thin-cap fibroatheromas
and plaque rupture from earlier progressive athero-
sclerotic lesions defined as pathological intimal
thickening or fibroatheromas. Macrophage infiltra-
tion of the arterial wall followed by low-density
lipoprotein uptake is an important step towards the
formation of atherosclerotic plaques (4). The for-
mation of a necrotic core is attributed mostly to the
macrophage death; free cholesterol within the ne-
crotic core, however, is derived from other sources
such as extravasated erythrocytes. It is well appre-
ciated that the cholesterol content of erythrocyte
membranes exceeds that of most other cells in the
body, with lipid constituting 40% of the weight.
Leaky immature intraplaque microvessels charac-
terized by poorly formed endothelial junctions orig-
inate from adventitial blood vessels called vasa
vasorum and penetrate into the intima in response
to tissue hypoxia. The growth of an elaborate
microvascular network around atherosclerotic
plaque permits inflammatory cell infiltration as well
as influx of blood constituents, especially erythro-
cytes, into the plaque. After hemorrhage, a bulk of the
erythrocytes is deposited in the plaque and is
degraded over days. Because membrane cholesterol
fraction cannot be metabolized by cells internally, it
becomes available for absorption into the expanding
necrotic core.
Hemorrhage and inﬂammation. In addition to con-
tributing to free cholesterol deposition within the
plaque, oxidative lysis of erythrocytes also releases
free hemoglobin (Hb), a source of oxidative damage
and reactive oxygen species (ROS) (5). The primary
defense mechanism against Hb-induced oxidative
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857damage is haptoglobin (Hp), which binds Hb with
high affinity and prevents loss of heme iron from
Hb. In atherosclerotic plaques, macrophages are the
only route for clearance of the Hb:Hp complex
through the CD163 receptor. Recent work has
identified that uptake of Hb:Hp complexes by
monocytes triggers a unique phenotype of macro-
phage characterized by expression of CD163 and
mannose (CD206) receptors. Interestingly, these
macrophages are distinct from lipid laden foam cells
in that they do not demonstrate evidence of cyto-
plasmic cholesterol ester accumulation and are in-
capable of being loaded with oxidized low-density
lipoprotein in vitro. Despite the fact that areas of
IPH demonstrate evidence of abundant iron depo-
sition, these areas do not show evidence of oxidative
deoxyribonucleic acid damage or protein nitration
due to reactive oxygen species such as OH° or
peroxynitrite (ONOO°). This is likely due to acti-
vation of antioxidant pathways within macrophages
including heme oxygenase-1 (HO-1), sequestration
of free iron by the intracellular iron binding protein
ferritin (which renders it redox inactive), and export
(out of the macrophage) and oxidation of iron via
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Figure 1. Pathophysiology and Molecular Consequences of Intr
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bound by the plasma protein transferrin. Mea-
surement of intracellular iron levels within
Hb:Hp exposed monocytes reveals lower levels of
free iron, consistent with these mechanisms.
Thus it appears that the inflammatory response to
hemorrhage is in part protective against the
potential consequences of iron or ROS-induced
tissue damage.
Macrophages in areas of IPH express minimal
amount of proinflammatory proatherogenic cyto-
kines such as tumor necrosis factor-alpha (TNF-)
and interferon-beta (IFN-) in comparison to foam
cells. Previous work has shown that uptake of oxi-
dized lipids into macrophages is facilitated by a
CD36 or toll-like receptor (TLR)-4/6 heterotrimer
to initiate signals propagated by TLR4 adaptor mol-
ecules. The initiation of downstream signaling re-
quires trafficking of TLR4 to lipid membrane mi-
crodomains, or lipid rafts. Because of the iron-
related antioxidant mechanisms activated within
macrophages in areas of hemorrhage, the suppres-
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858sion of ROS inhibits lipid-mediated inflammatory
signaling responses.
While the aforementioned consequences of
the macrophage inflammatory response to hem-
orrhage suggest these cells may be atheropro-
tective, an important but unresolved issue is
whether these macrophages participate in the
resolution of plaque angiogenesis (that likely
was the cause of hemorrhage in the first place),
or actively contribute to it. Although hypoxia-
dependent molecular mechanisms of angiogene-
sis are well recognized, especially activation of
the transcription factor hypoxia inducible factor-1
alpha (HIF-1), hypoxia-independent mechanisms
of HIF-1 also exist. Some of these involve an
important role for iron in activating proteins. Sun J, Underhill HR, Hippe DS, Xue
Y, Yuan C, Hatsukami TS. Sustained
4
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al. Hemoglobin direcWhen iron is sequestered as seen in macro-
phage in areas of IPH, it is also possible that
the activity of HIF-1  and its target proangio-
genic genes such as vascular endothelial growth
factor (VEGF) is increased. The concept that
hemorrhage may beget more hemorrhage through
its effects on macrophage-mediated neovasculariza-
tion is supported by the studies such as one by Sun
et al. (3) demonstrating that IPH may not resolve
rapidly. . . if at all.
Given the accumulating evidence (3,6,7), it seems
logical to conclude that IPH is a major driver of
plaque growth. Although therapeutic options at the
present time are limited, we will need to continue to
understand better the natural history of IPH
(Fig. 1) to develop interventions to prevent IPH asthat control activity of HIF-1 such as PHD2. well as its deleterious consequences.6
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